FeedBagel

All Topics

Art

Pfizer-Mylan Merger: The Making of The Pharma Giant

MarketsandMarkets

6y agoen

business pharmaceuticals

Source

marketsandmarkets.comPfizer-Mylan Merger: The Making of The Pharma Giantmarketsandmarkets.com

Snippet from the RSS feed

Pfizer, Inc., is one of the world’s leading biopharmaceutical companies whose portfolio includes medicines, vaccines, and consumer healthcare products. During the last decade, the company has been focused to strengthen their global position in branded prescription drugs through internal restructuring and divestments. Similarly, Mylan NV, is a global giant that has a strong geographic presence… Continue reading Pfizer-Mylan Merger: The Making of The Pharma Giant

You might also wanna read

Medicare Launches $50/Month GLP-1 Weight-Loss Drug Trial: What Beneficiaries Need to Know

Starting this week, the federal government launched a new trial program called Medicare GLP-1 Bridge, offering certain GLP-1 agonist medicat

medpagetoday.com·4d ago

Trump administration's kratom ban benefits rival supplement makers who lobbied for the change

The article reports on the Trump administration's move to ban a potent synthetic version of kratom, which benefits makers of rival botanical

nytimes.com·6d ago

States target pharmacy benefit managers with new laws to lower prescription drug costs

States across the U.S. are passing laws to regulate pharmacy benefit managers (PBMs) — middlemen that manage prescription drug coverage for

apnews.com·10d ago

UK Medical Cannabis Imports Double for Second Straight Year, Market Poised for 40,000+ New Patients by 2026

The UK medical cannabis market is experiencing explosive growth, with imports of cannabis-based medicinal products (CBPMs) surpassing 30,000

businessofcannabis.com·10d ago

States target pharmacy benefit managers with new laws to lower prescription drug costs

States across the U.S. are passing laws to regulate pharmacy benefit managers (PBMs) — middlemen that manage prescription drug coverage for

apnews.com·10d ago

Vaxart approaches key COVID-19 vaccine pill trial readout as it seeks to rebound from turbulent year

Vaxart, a San Diego-based vaccine developer, is preparing for a key readout from its COVID-19 vaccine-pill trial after a turbulent year. The

cen.acs.org·14d ago

Comments

No comments yet. Be the first.